Portfolio company
NuvoBio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company provides artificial intelligence software to design target-specific peptide therapeutics for pharmaceutical and biotechnology organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AilsynBio
This biotechnology company provides an artificial intelligence platform for peptide drug discovery and manufacturing services to pharmaceutical and healthcare organisations.
Meddenovo
This company develops an artificial intelligence platform for de novo cyclic peptide drug discovery to support pharmaceutical and biotechnology firms.
DeepSeq.AI
DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.
Regenova Pharmaceuticals
The company develops antibody and nanobody therapeutics for pharmaceutical and biotechnology firms using an artificial intelligence-driven drug discovery platform.
Oncocine
The company develops an artificial intelligence platform to design mRNA cancer vaccines for pharmaceutical and biotechnology organisations.
Avicenna Biosciences
The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.
Nabla Bio
This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.
Inceptive Nucleics
This company develops artificial intelligence models to design novel RNA-based medicines and biotechnologies for pharmaceutical and biotechnology partners.
